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Reversible redox modification of cysteine thiols is crucial for protecting proteins from irre-
versible detrimental change. However, the physiological significance of the redox modifi-
cation of apolipoprotein (apo) E is unclear. Here, we hypothesized that the disulfide-linked
complexes of apoE3 corresponding to the representative reversible-modified apoE3 play
a protective role against oxidative stress. The effects of disulfide bond formation on ox-
idative stress on apoE3 were evaluated with a band-shift assay. Maleimide-labeled apoE3
and unlabeled apoE3 were defined as the reduced (r)-apoE3 and non-reduced (nr)-apoE3
forms, respectively. Hydrogen peroxide-induced oxidation decreased for reduced-form
apoE (r-apoE3) but increased for nr-apoE3. Induction of apoE3-AII complex formation with
excess of apoAII markedly suppressed the oxidative stress-induced increase in nr-apoE3
(P<0.001) and enhanced homodimer formation. The apoE3-AII complex was more domi-
nant in high-density lipoprotein (HDL) than in very low-density lipoprotein. Under oxidative
stress, HDL showed a significant decrease, rather than an increase, in nr-apoE3 levels with
a concomitant significant increase in apoE3-AII levels (P<0.005). This finding suggests that
the majority of nr-apoE3 in HDL exists in a reversible oxidized form. The apoE3-AII com-
plex, formed from the reversible oxidized apoE3, is beneficial for maintaining the redox
equilibrium of apoE3 by preventing the modification of apoE3 to its irreversible oxidized
form. The apoE3-AII complex may be possibly implicated in the pathophysiology of various
apoE-related diseases.
Introduction
Apolipoprotein E (apoE), a 35-kDa glycoprotein comprising 299 amino acids residues, is primarily synthe-
sized in the liver and plays a pivotal role in lipid transport and metabolism [1]. In addition, it is expressed
in the brain and is involved not only in cerebral lipid metabolism, but also in the growth and repair of the
central nervous system [2]. Human apoE has three major isoforms—apoE2, apoE3, and apoE4—that are
the products of three independent alleles at a single locus [1]. The structural variances in these isoforms
have led to functional changes and pathological consequences [2]. In fact, apoE has been shown to play a
role in the development of various diseases [3]. In particular, apoE4 is a major causative factor of sporadic
late-onset Alzheimer’s disease (AD) and its frequency ismarkedly increased in AD [4]. On the other hand,
in another study, apoE4 was not present in approximately 30% of the patients with AD [5]. Although the
actual role of apoE4 in the development of AD is yet unclear, the knowledge of the pathological alter-
ations in other isoforms during AD development may lead to a promising breakthrough in AD pathology.
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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The cysteine–arginine interchange at 112, 158, or both is one of the major features that distinguish apoE2 and
apoE3 from apoE4. The presence of cysteine allows apoE2 and apoE3 to form homodimers through a disulfide bond
[6]. These isoforms also bind to apoAII, a plasma protein of 8.7 kDa, via their cysteine residue to form apoE het-
erodimers, i.e., apoE-AII complex (apoE-AII) and apoAII-E2-AII complex [7,8]. Previous studies have shown that
these variations impact the distribution of apoE in lipoprotein particles; the preference of apoE3 for high-density
lipoprotein (HDL) and apoE4 for very low-density lipoprotein (VLDL) results from the differences in the charge at
residue 112 and the ability to form apoE-AII [9]. These characteristics also affect the pathophysiological functions
of apoE. Several studies have demonstrated that the dimerization of apoE3 results in a significant increase in the
synthesis of HDL [10,11].
Cysteine thiol, a highly reactive residue in proteins, is subjected to post-translational redox-mediatedmodifications
(e.g., hyperoxidation, nitrosylation, glutathionylation, and palmitoylation) [12,13]. To date, several studies have sug-
gested that the redox status of cysteine thiol may greatly affect various biological activities [14–16]. We have recently
suggested that the redox status of serum apoE may depend on its cysteine thiol modification and is closely related to
the synthesis of HDL [17].
Redox-mediated alterations of cysteine thiol residues are either reversible or irreversible, and apoE disulfide com-
plexes such as homodimers and heterodimers correspond to the forms with reversible alterations. The irreversible
modification of the cysteine thiol residue is predicted to cause loss-of-function, leading to the degradation of the
modified protein [18,19]. In contrast, the temporary alteration of a protein due to reversible modifications is crucial
for the protection of the protein from irreversible detrimental changes as well as for the modulation of protein func-
tion [20]. Based on their reversible properties, the apoE disulfide-linked complexesmay be committed tomaintaining
their redox status and regulating their functions, consequently impacting the pathophysiology of various apoE-related
diseases such as AD and cardiovascular diseases.
Based on the above hypothesis, we investigated the effect of apoE-AII on oxidative stress in subjects with apoE3,
the most common isoform, to clarify its role in the redox status of apoE-containing lipoproteins.
Materials and methods
Materials
Photocleavable maleimide-conjugated polyethylene glycol (PEG-PC-Mal; MW, 2736 Da) was purchased from Do-
jindoMolecular Technologies, Inc. (Kumamoto, Japan). Recombinant apoE3 was obtained from BioVision Inc. (Mil-
pitas, CA, U.S.A.) and horseradish peroxidase (HRP)-conjugated anti-apoE polyclonal antibody was supplied by
Academy Bio-medical Co. (Houston, TX, U.S.A.). All other chemicals used were of the highest grade.
Preparation of apoE3-containing lipoprotein fractions
Serum apoE3-containing lipoproteins, VLDL (<1.006 kg/l) and HDL (1.063–1.21 kg/l), were isolated from the sera
of healthy volunteers with apoE phenotype E3/E3 (n=3, apoE, 27.0 +− 6.1 mg/l) using an ultracentrifugation method
as previously described [21]. The serum apoE phenotype was determined by isoelectric focusing and immunoblot
analysis as previously described [22]. The present study was approved by the Tsukuba University Ethics Committee
and all volunteers provided written informed consent.
Analysis of apoE redox status
The redox status of apoE was analyzed with a band-shift assay using polyethylene glycol maleimide (PEG-PC-Mal),
according to our previous study [17]. Briefly, PEG-PC-Mal was added to the sample at a final concentration of 1.0
mmol/l. The mixture was incubated for 30 min at 37◦C, followed by electrophoresis using 10% SDS/PAGE under
non-reducing condition. After electrophoresis, the gel was UV-irradiated for 15 min to eliminate the PEG moi-
ety, and the separated proteins were transferred onto a polyvinylidene fluoride membrane. The blots were probed
with an HRP-conjugated anti-apoE polyclonal antibody. The specific bands were developed using an ECL detec-
tion kit (Nacalai Tesque, Inc., Kyoto, Japan), and were analyzed using ImageJ 1.45 software from the National Insti-
tutes of Health. As previously described [17], a 40-kDa labeled apoE3 was defined as the reduced form (r) of apoE3,
while the monomeric form (35-kDa unlabeled apoE3) remaining in the presence of PEG-PC-Mal was termed as the
non-reduced form (nr) of apoE3 (Figure 1). In addition to these bands, as previous studies have well confirmed [6,9],
the bands with molecular masses of 47.0 and 95.0 kDa were defined as the apoE3-AII and homodimer, respectively.
The levels of the homodimer, apoE3-AII, reduced-form apoE (r-apoE3), and nr-apoE3 were estimated from the den-
sitometric values of these bands.
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Figure 1. Typical pattern of the band-shift assay using polyethylene glycol maleimide (PEG-PC-Mal)
Healthy volunteer’s serum was incubated with PEG-PC-Mal. The band-shift assay was performed using HRP-conjugated anti-apoE
antibody, as described in Materials & Methods.
Determination of apoE and apoAII
The levels of apoE and apoAII were determined by enzyme-linked immunosorbent assay and turbidimetric im-
munoassay, respectively, using a commercially available kit.
Statistical methods
Data are presented as mean +− standard error (S.E.). Statistical analysis was performed using either a paired t-test or
an unpaired t-test depending on the dataset. A value of P<0.05 was considered as significant.
Results
Redox proﬁles of apoE3 in VLDL and HDL
The redox profiles of apoE3 in VLDLs and HDLs isolated from the sera of three healthy volunteers with apoE3/E3
phenotype were determined by the band-shift assay using PEG-PC-Mal. As per our previous findings [17], naive
VLDL and HDL showed differences in the redox status of apoE3; i.e., r-apoE3 was more dominant in VLDL than in
HDL (P<0.05), whereas the apoE3-AII level was higher in HDL (P<0.05) (Table 1).
Inﬂuence of oxidative stress on the redox status of apoE3
To investigate the influence of oxidative stress on the redox status of apoE3, we added hydrogen peroxide (H2O2) at
final concentrations of 0, 0.3, 0.6, and 1.2 mM to either recombinant apoE3 or to each of the three above-mentioned
VLDLs. We performed the band-shift assay using these mixtures (Figure 2A). The oxidation with H2O2 significantly
decreased the levels of r-apoE3 in both recombinant apoE3 (0.43-fold, P<0.001) and VLDL (0.24-fold, P<0.001)
compared with the non-oxidized controls (Figure 2B). In contrast, the oxidation with H2O2 dose-dependently in-
creased nr-apoE3 levels in both recombinant apoE3 and VLDL (Figure 2C). However, a gradual change in nr-apoE3
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Table 1 Redox Proﬁles of apoE3 in VLDL and HDL
Sample apoE (mg/l) fraction (%)
r-apoE3 nr-apoE3 apoE3-AII homodimer
VLDL
S1 15.1 15.2 27.5 39.6 17.8
S2 12.6 17.9 29.3 33.1 19.7
S3 14.2 21.9 25.7 34.3 18.1
mean +− SE 14.0 +− 0.7* 18.33 +− 1.95* 27.50 +− 1.04 35.67 +− 2.00* 18.53 +− 0.59
HDL
S1 10.4 11.5 30.6 42.0 16.0
S2 11.0 7.7 25.8 45.1 21.4
S3 12.1 10.4 28.3 44.4 16.9
mean +− SE 11.2 +− 0.5 9.87 +− 1.13 28.23 +− 1.39 43.83 +− 0.94 18.10 +− 1.67
S1∼S3, sera obtained from healthy volunteers with apoE phenotype E3/E3.
*P<0.05 (vs HDL).
level was observed in VLDL compared with in recombinant apoE3. The fluctuations in homodimer levels were dif-
ferent between recombinant apoE3 and VLDL (Figure 2D). The homodimer levels in recombinant apoE3 were sig-
nificantly reduced upon oxidation at more than 0.6 mMH2O2 concentration (0.73-fold, P<0.001), although the level
was almost unchanged following oxidation with 0.3 mMH2O2. In contrast, the homodimer levels in VLDL were sig-
nificantly increased following oxidation and displayed a peak value upon incubation with 0.6 mM H2O2 (1.67-fold,
P<0.001). The levels of apoE3-AII present in VLDL, but not in recombinant apoE3, significantly decreased following
oxidation with more than 0.6 mM H2O2 (P<0.05), although no change was observed in response to treatment with
0.3 mMH2O2 (Figure 2E).
Inﬂuence of apoAII on the redox status of apoE3
To assess the influence of apoAII on the redox status of apoE3 in na¨ıve VLDL, we incubated each of the three
above-mentioned VLDLs with an excess of recombinant apoAII at a final concentration of 650 mg/l and performed
the band-shift assay. The formation of apoE3-AII was significantly induced after the addition of the recombinant
apoAII (P<0.001), and a less than 5% reduction in nr-apoE3 level was observed (P<0.005). No differences in the
levels of r-apoE3 and the homodimer were observed in the presence and absence of recombinant apoAII (Figure 3).
Effect of apoAII against oxidative stress on apoE3
We examined whether apoAII acts against oxidative stress on apoE3 and evaluated its role in the maintenance of
redox status. We incubated each of the three above-mentioned VLDLs with recombinant apoAII and subjected the
samples to oxidation with H2O2. The band-shift assay was performed using these mixtures (Figure 4A). Regardless of
the presence or absence of the recombinant apoAII, r-apoE3 levels reduced in response to H2O2-mediated oxidation
(Figure 4B). On the other hand, nr-apoE3 levels showed a dose-dependent increase in the absence of recombinant
apoAII following treatment with H2O2. In the presence of recombinant apoAII, although nr-apoE3 levels were sig-
nificantly induced upon oxidation with more than 0.6 mM H2O2, the levels were lower than those in the absence
of recombinant apoAII. In addition, similar to the non-oxidized control, nr-apoE3 was almost undetectable under
oxidizing conditions with 0.3 mM H2O2 (Figure 4C). Homodimer levels increased following H2O2-mediated oxi-
dation, irrespective of the presence or absence of recombinant apoAII; however, different fluctuation patterns were
observed between the two conditions. Homodimer levels increased significantly more in the presence rather than in
the absence of recombinant apoAII (2.61-fold for the oxidizing condition with 0.3 mMH2O2, P<0.001). In addition,
homodimer levels peaked in the presence of recombinant apoAII following oxidationwith 0.3mMH2O2. On the con-
trary, in the absence of recombinant apoAII, the peak value was observed following oxidation with 0.6 mM H2O2.
Under both conditions, the H2O2 concentration required to attain the peak value of homodimer levels was equal to
that required to obtain the lowest level of apoE3-AII (Figure 4D). The apoE3-AII levels decreased by approximately
60% in comparison to the levels observed for the non-oxidized control group in the presence of more than 0.3 mM
H2O2; however, the levels remained almost constant regardless of H2O2 concentration and were significantly higher
than those in the absence of recombinant apoAII (1.78–2.78-fold, P<0.01) (Figure 4E).
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Figure 2. Inﬂuence of H2O2 oxidation on the redox status of apoE3
Recombinant apoE3 (10.0 mg/l) or each of the three VLDLs (n=3, apoE concentration, 12.0 +− 2.9 mg/l) was incubated with serially
diluted H2O2 at final concentrations of 0, 0.3, 0.6, and 1.2 mM for 15 min at 37◦C. The reaction was quenched by the addition of
tris (2-carboxyethyl) phosphine into ammonium bicarbonate buffer, and the band-shift assay was carried out using PEG-PC-Mal as
described in Materials & Methods (A). After densitometry, we analyzed the changes in the relative levels of r-apoE3 (B), nr-apoE3
(C), homodimer (D), and apoE3-AII (E) and compared the values with those obtained for the non-oxidized controls. The values
shown are the mean +− S.E. from duplicate measurements of each sample from three independent experiments. *, P<0.05 and **,
P<0.001 as compared with the non-oxidized recombinant apoE3 or VLDL (0 mM H2O2).
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 3. Inﬂuence of apoAII on the redox status of apoE3
Each of the three VLDLs was incubated with an equal volume of saline or recombinant apoAII at a final concentration of 650 mg/l at
37◦C overnight. The band-shift assay using these mixtures was performed as described in Materials & Methods. After densitometry,
we analyzed the rate of change in r-apoE3, nr-apoE3, homodimer, and apoE3-AII levels. The values shown are the mean +− S.E.
from duplicate determinations of each sample from three independent experiments. The values shown are the mean +− S.E. from
duplicate determinations of each sample from three independent experiments. *, P<0.005 and **, P<0.001.
Inﬂuence of oxidation on the redox status of apoE3-containing
lipoproteins
To examine whether the behavior of the apoE3 redox status under oxidative stress was different among lipoproteins,
we incubated each of the three above-mentioned VLDLs andHDLs with 0.6 mMH2O2 and performed the band-shift
assay using these mixtures. As previously demonstrated [23], apoAII was more abundant in HDL (677 +− 93 mg/l)
than in VLDL (undetectable). In accordance with the above results, H2O2 oxidation decreased the level of r-apoE3
and increased the level of homodimer. The rate of change in r-apoE3 and homodimer levels from HDL tended to
be greater than that from VLDL. On the other hand, the alterations in nr-apoE3 and apoE3-AII levels from HDL
were different from those from VLDL. Under oxidative stress, HDL showed a significant decrease, rather than an
increase, in the nr-apoE3 level with a concomitant significant increase in the apoE3-AII level (P<0.005), whereas
VLDL showed no significant changes (Figure 5).
Discussion
Oxidative stress causes reversible or irreversible protein modifications and is involved in the pathogenesis of various
diseases [24–26]. The reversible modification of the cysteine thiol of proteins, represented by disulfide bond forma-
tion, has a significant impact on diverse physiological functions by protecting proteins from irreversible detrimental
changes [20]. Hence, the present study was designed to test whether the disulfide-linked complexes of apoE3, espe-
cially apoE3-AII, play a protective role against oxidative stress.
The redox profiles of apoE3 in VLDL and HDL were consistent with those in our previous studies [17], although
these data derived from small-scale experiments. Further studies will be necessary to clarify whether the intensities
of the apoE bands developed using HRP-conjugated anti-apoE polyclonal antibody are comparable among r-apoE,
nr-apoE, apoE3-AII, and the apoE homodimer. However, relative but not absolute comparisonmay be sufficient, even
by the present method.
We showed the differences in the behavior of recombinant apoE3 and apoE3 from VLDL to oxidative stress. The
oxidative stress–induced increase in nr-apoE3 was more prominent in recombinant apoE3 than in VLDL, suggesting
6 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 4. Effect of apoAII on the oxidative stress against apoE3
Each of the three VLDLs was incubated with an equal volume of saline or recombinant apoAII at a final concentration of 650 mg/l at
37◦C overnight, followed by oxidation with H2O2 at a final concentration of 0, 0.3, 0.6, or 1.2 mM for 15 min at 37◦C. The reaction
was quenched by the addition of tris (2-carboxyethyl) phosphine in ammonium bicarbonate buffer, and the band-shift assay was
carried out using PEG-PC-Mal, as described in Materials & Methods (A). The band intensities of r-apoE (B), nr-apoE (C), homodimer
(D), and apoE3-AII (E) were determined through densitometry. The values shown are the mean+− S.E. from duplicate determinations
of each sample from three independent experiments. *, P<0.05 and **, P<0.001 as compared with each non-oxidized control (0 mM
H2O2). #, P<0.01 and ##, P<0.001 as compared with each recombinant apoAII-free sample under the same oxidation conditions.
that recombinant apoE3 is more susceptible to oxidative stress as compared with apoE3 from VLDL. In the case of
recombinant apoE3, the reduction in the levels of r-apoE3 and the homodimer was obviously related to the increase
in the level of nr-apoE. Hence, the oxidation state of nr-apoE3 may be higher than that of the homodimer. In other
words, further oxidation of nr-apoE3 may be more difficult to achieve in comparison with that of the homodimer.
It is interesting that the increase in the level of nr-apoE3 in VLDL was not as remarkable as that observed in recom-
binant apoE3. In addition, a marked increase in the level of homodimers was observed for VLDL rather than for
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 5. Inﬂuence of oxidation on the redox status of apoE3-containing lipoproteins
Each of the three VLDLs and HDLs was adjusted to equal the apoE concentration and incubated with 0.6 mM H2O2 for 15 min
at 37◦C. The reaction was quenched by the addition of tris (2-carboxyethyl) phosphine in ammonium bicarbonate buffer, and the
band-shift assay was carried out using PEG-PC-Mal as described in Materials & Methods. After densitometry, we analyzed the
rate of change in r-apoE3, nr-apoE3, homodimer, and apoE3-AII levels. The values shown are the mean +− S.E. from duplicate
determinations of each sample from three independent experiments. *, P<0.005.
recombinant apoE3, consistent with the reduction in the level of apoE3-AII. These results suggest that the difference
in the fluctuation of homodimer levels between recombinant protein and VLDL may be attributed to the presence
or absence of apoE3-AII. The newly synthesized homodimer in VLDL after H2O2-mediated oxidation may comprise
apoE3molecules derived from apoE3-AII; i.e., the redox reactivity of the homodimer is lower than that of apoE3-AII.
Also of interest are the notable effects of apoAII on the redox status of apoE3 in naive VLDL. The addition of
an excessive amount of recombinant apoAII dramatically reduced the level of nr-apoE3 with a simultaneous forma-
tion of apoE3-AII, suggesting that the majority of nr-apoE3 (PEG-PC-Mal-unlabeled apoE3) may be present in a
reversible oxidized form, derived from modifications, such as sulfenylation, S-nitrosylation, S-glutathiolation, and
S-cysteinylation, even though we have previously postulated that nr-apoE3 was an irreversible oxidized form [17].
On the other hand, there is no doubt that an oxidation-induced nr-apoE3 is the true irreversibly oxidized form.
Intriguingly, the presence of excessive apoAII prominently suppressed the increase in nr-apoE3 levels with a con-
comitant significant increase in the level of apoE3-AII and caused a greater increase in homodimer formation under
lower oxidative stress. Also, the increase in the level of homodimers seemed associated with a simultaneous reduc-
tion in the level of apoE3-AII. Overall, these findings suggest that apoE3-AII and the homodimer may possibly be
involved in imparting protection from oxidative stress while maintaining equilibrium with each other.
It is well known that apoAII exists predominantly in the HDL fraction [23]. The results of the present study are in
line with those previously reported. In addition, previous studies have demonstrated that apoE3-AII and the homod-
imer prefer HDL over VLDL [9]. On the basis of these evidences, it is expected that apoE3 in HDL would be more
resistant to oxidation than apoE3 inVLDL. Indeed, nr-apoE3 levels inHDLdecreased after oxidation, in contrast with
the result observed with VLDL. This finding suggests that most of nr-apoE3 inHDLmay exist as a reversible oxidized
form and may protect apoE3 molecules from further oxidation through the formation of apoE3-AII or the homod-
imer. On the contrary, the increased nr-apoE3 in VLDL may be the irreversibly oxidized form derived from r-apoE3
and disulfide-linked complexes. The opposite changes in apoE3-AII betweenHDL and VLDLmay be associated with
the significant differences in the amount of apoAII. As HDL is rich in apoAII, the substrate for apoE3-AII, the forma-
tion of the complex is facilitated in response to oxidative stress andmay consequently prevent the further oxidation of
the cysteine thiol of apoE3. By contrast, apoE3-AII in VLDL, which originally contains a low concentration of apoAII,
8 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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may be susceptible to further oxidation. Of note, the rate of change of the apoE homodimer level tended to be higher
for HDL than in VLDL, suggesting that the homodimer may also serve as a buffer against irreversible oxidation by
maintaining an equilibriumwith apoE3-AII. In addition, it would be interesting if the dimerization of apoE3 was also
found to protect against the oxidation of other highly reactive amino acid residues, such as methionine.
We hypothesize that although oxidative stress causes a graded increase in the oxidation state of the cysteine thiol
in the apoE3 molecule, the equilibrium between apoE3-AII and the homodimer can prevent the irreversible oxi-
dation, especially under apoAII- or apoE3-AII–abundant conditions. Disulfide bond formation may maintain the
function of the apoE3 molecule, although the redox reactivities of apoE3-AII and the homodimer are lower than that
of monomeric r-apoE3. This hypothesis is strongly supported by the fact that apoE3 shows a high ability to synthesize
HDL, which is attributable to the formation of disulfide-linked complexes [9]. However, one limitation of our study
was the use of H2O2 at high concentrations, which are far from physiological. Hence, further experiments under near
physiological conditions will be necessary to confirm the pathophysiological effects of oxidative stress.
As apoE4 with various detrimental properties [3,27] exists as the only monomeric form owing to the absence of
any cysteine residue, the monomeric irreversibly oxidized apoE3 may behave like apoE4. Although further studies
are warranted to examine how the redox status of apoE3 affects its function, our observations in the present study
suggest that the formation of the disulfide-linked complexes is certainly beneficial for maintaining the redox status of
apoE3 by preventing the formation of the detrimental irreversibly oxidized form in response to oxidative stress. The
disulfide-linked complexes of apoE3, especially apoE3-AII, may be implicated in the pathophysiology of apoE-related
diseases such as AD.
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